P-093
Phenazepam-D4 solution
100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C15H6D4N2OBrCl
化学文摘社编号:
分子量:
353.63
NACRES:
NA.24
UNSPSC Code:
41116107
EC Number:
200-835-2
InChI key
ATCCWKYKHCKDGT-RALIUCGRSA-N
InChI
1S/C15H11BrN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)/i1D,2D,3D,4D,5D
SMILES string
BrC1=CC2=C(NC(CN=C2C3=C([2H])C([2H])=C([2H])C([2H])=C3[2H])=O)C=C1
grade
certified reference material
form
liquid
feature
(Snap-N-Spike®)
packaging
ampule of 1 mL
manufacturer/tradename
Cerilliant®
drug control
Narcotic Licence Schedule B (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)
concentration
100 μg/mL in acetonitrile
technique(s)
gas chromatography (GC): suitable, liquid chromatography (LC): suitable
application(s)
clinical testing
format
single component solution
storage temp.
−20°C
Quality Level
General description
A benzodiazepine developed in Russia, phenazepam is used in Europe for treatment of epilepsy, alcohol withdrawal syndrome, and insomnia. Phenazepam has gained popularity as a recreational drug and is sold under street names such as Zannie, Bonzai, Bonzai Supersleep, and Kronic. This Certified Spiking Solution® is suitable for use as an internal standard for quantification of phenazepam in urine or other biological matrices by LC/MS or GC/MS.
Legal Information
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Danger
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
存储类别
3 - Flammable liquids
wgk
WGK 2
flash_point_f
35.6 °F - closed cup
flash_point_c
2.0 °C - closed cup
法规信息
监管及禁止进口产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持